The impact of acute illness on HbA1c determination of undiagnosed diabetes

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 7, 2012, Pages 603-607

  Thakker, Urvi ^a   Ellman, Tovah ^a   Magleby, Reed ^a   Graff, Kirsten ^a   Kelson, James ^b   Silverman, Robert A ^a,c  

^a North Shore LIJ Health System   (United States)

^b Northwell Health   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Acute care; Diabetes; HbA1c; Screening

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ACUTE DISEASE; ADULT; ARTICLE; DIABETES MELLITUS; DIAGNOSTIC VALUE; EMERGENCY CARE; FEMALE; HEMOGLOBIN ANALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING TEST;

ACUTE DISEASE; ADULT; AGED; DIABETES MELLITUS; EMERGENCY SERVICE, HOSPITAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, TEACHING; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEW YORK; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; VOLUNTARY HEALTH AGENCIES;

EID: 84867064675     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2315     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA, 2011. http://www.cdc/gov/diabetes/pubs/pdf/ndfs_2011.pdf [10 June 2011].
2. Harris MI, Klein R, Welborn TA, et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
3. Koopman RJ, Mainous AG, Liszka HA, et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med 2006; 4: 427-432.
4. Spijkerman AM, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The Hoorn Screening Study. Diabetes Care 2003; 26: 2604-2608.
5. Preventing Chronic Diseases: Investing Wisely in Health. Preventing diabetes and its complications [article online], 2008. Available from http://www.cdc.gov/chronicdisease/resources/publications/factsheets/pdf/diabetes.pdf [25 March 2010].
6. Standards of medical care in diabetes - 2009. Diabetes Care 2009; 32(Suppl. 1): S13-S61.
7. Ealovega MW, Tabaei BP, Brandle M, et al. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 2004; 27: 9-12.
8. Executive summary: standards of medical care in diabetes - 2010. Diabetes Care 2010; 33(Suppl. 1): S4-S10.
9. Little RR, Rohlfing CL, Wiedmeyer HM, et al. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001; 47: 1985-1992.
10. Stratton IM, Adler AI, Neil AW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
11. Pitts SR, Niska RW, Xu J, et al. National hospital ambulatory medical care survey: 2006 emergency department summary. Natl Health Stat Report 2008; 7: 1-38.
12. Tahara Y, Shima K. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care 1993; 16: 1313-1314.
13. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995; 18: 440-447.
14. Tarim O, Kucukerdogan A, Gunay U, Eralp O, Ercan I. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int 1999; 41: 357-62.
15. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004; 112: 126-8.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
17. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48(3): 436-72.
18. 1c assays. Clin Chim Acta 2006; 372: 206-09.
19. 1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000; 23: 187-191.
20. 1c in predicting progression to diabetes in French men and women: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006; 29: 1619-1625.
21. Edelman D, Olsen MK, Dudley TK, et al. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004; 19: 1175-1180.
22. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17: 107-124.
23. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995; 98: 75-84.
24. Greci LS, Kailasam M, Malkani S, et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 2003; 26: 1064-1068.
25. Okosieme OE, Peter R, Usman M, et al. Can admission and fasting glucose reliably identify undiagnosed diabetes in patients with acute coronary syndrome? Diabetes Care 2008; 31: 1955-1959.
26. Gray CS, Scot JF, French JM, et al. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 2004; 33: 71-77.
27. Michelle AC, Ipp E, Kaji AH, et al. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients. Acad Emerg Med 2009; 16: 394-402.
28. 1c affected by glycemic instability? Diabetes Care 2003; 26: 2728-2733.
29. 1c levels than glucose instability. Diabetes Care 2006; 29: 352-355.
30. Beach KW. A theoretical model to predict the behavior of glycosylated hemoglobin levels. J Theor Biol 1979; 81: 547-561.